SCRNA seq data in this field has not yet addressed CAF subpopulation and treatment resistance or patient prognosis extensively, although the existing data generally associate myCAFs and TGFb with poorer outcome, as well as tumor biology relevant to tumor inflammation. Here, TGFB1 is linked to neoplasm.